INIT.ST

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Biotechnology

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2026	$54M	+7.6%	$-0.61	$-0.61–$-0.61	—	1
2027	$67M	+24.7%	$-0.34	$-0.34–$-0.34	—	1
2028	$12M	-82.4%	$-0.46	$-0.46–$-0.46	—	1

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

DCF fair valuemodel estimate

Intrinsic value

$0.64

Price

$2.25

Implied downside

-72%

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
INIT.STInitiator Pharma A/S	$2.33	+1.75%	$159M	—
ALZ.STAlzinova AB (publ)	$0.46	-0.87%	$47M	—
ANNX.STAnnexin Pharmaceuticals AB	$12.80	+0.79%	$92M	—
BIOWKS.STBio-Works Technologies AB (publ)	$3.21	+1.90%	$266M	—
CLS-B.STClinical Laserthermia Systems AB (publ)	$1.99

Initiator Pharma A/S

Initiator Pharma A/S is a clinical-stage life sciences firm dedicated to discovering therapeutic solutions for critical unmet medical needs affecting the central and peripheral nervous systems. Its development pipeline features several clinical-phase compounds: IP2018, a monoamine reuptake inhibitor aimed at psychogenic erectile dysfunction; IPED2015, designed to address organic erectile dysfunction; and IPTN2021, an orphan drug candidate for severe neuropathic pain. Additionally, the company holds early-stage assets, including IPNP2015 for chronic pain management and IPDP2015 for depression. Established in 2016, Initiator Pharma A/S maintains its headquarters in Copenhagen, Denmark.

www.initiatorpharma.com

Employees: 1
IPO / List date: Mar 16, 2017
HQ: DK

Held by traders on TradeandTell

No one on the platform currently holds INIT.ST.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in INIT.ST as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded INIT.ST yet.